Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts.

Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts.

Item
http://www.wikidata.org/entity/Q34797430
Platinum-induced hearing loss after treatment for childhood cancerPharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical UsePharmacogenomics in Pediatric Patients: Towards Personalized MedicinePlatinum-induced ototoxicity: a review of prevailing ototoxicity criteria.Pharmacogenetic variants in TPMT alter cellular responses to cisplatin in inner ear cell linesDesign and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort Study.The role of germline variants in chemotherapy outcome in brain tumors: a systematic review of pharmacogenetic studies.TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity.Role of Preemptive Genotyping in Preventing Serious Adverse Drug Events in South Korean Patients.Promoter region variation in NFE2L2 influences susceptibility to ototoxicity in patients exposed to high cumulative doses of cisplatin.Pharmacogenetic analysis of irreversible severe cisplatin-induced nephropathy: a case report of a 27-year-old woman.Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin.Systematic review of pharmacogenomics and adverse drug reactions in paediatric oncology patients.DNA methylation of a novel PAK4 locus influences ototoxicity susceptibility following cisplatin and radiation therapy for pediatric embryonal tumors.Ototoxicity: A Challenge in Diagnosis and Treatment.
P2860

Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts.

Item
http://www.wikidata.org/entity/Q34797430
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Influence of genetic variants ...... heterogeneity between cohorts.
@ast
Influence of genetic variants ...... heterogeneity between cohorts.
@en
Influence of genetic variants ...... heterogeneity between cohorts.
@nl
type
label
Influence of genetic variants ...... heterogeneity between cohorts.
@ast
Influence of genetic variants ...... heterogeneity between cohorts.
@en
Influence of genetic variants ...... heterogeneity between cohorts.
@nl
prefLabel
Influence of genetic variants ...... heterogeneity between cohorts.
@ast
Influence of genetic variants ...... heterogeneity between cohorts.
@en
Influence of genetic variants ...... heterogeneity between cohorts.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Influence of genetic variants ...... heterogeneity between cohorts
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0115869
P407
P433
P478
P50
P577
P5875
P698
P932